Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV

Taki, E; Soleimani, F; Asadi, A; Ghahramanpour, H; Namvar, A; Heidary, M

Heidary, M (通讯作者),Sabzevar Univ Med Sci, Sch Paramed Sci, Dept Lab Sci, Sabzevar, Iran.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022; 20 (8): 1135